First Eczema Biologic Debuts but Price Could Restrict Use
May 9, 2017
The US Food and Drug Administration has approved the first biologic therapy for atopic dermatitis, the itchy skin condition better known as eczema.
Continue reading here.
Fresh treatments shift the focus from symptom management to repair.
Smart algorithms take aim at antimicrobial resistance.